U.S. market Closed. Opens in 8 hours 43 minutes

PTPI | Petros Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue5.82M5.99M7.81M9.56M15.58M14.05M
Cost of Revenue1.63M2.29M1.60M4.05M7.43M10.48M
Gross Profit4.19M3.70M6.21M5.51M8.15M3.57M
Operating Expenses17.81M19.55M24.26M22.80M25.02M11.22M
Selling, General & Admin9.26M12.21M15.59M15.67M19.73M11.22M
Research & Development2.41M1.74M1.79M459.64KN/AN/A
Other Operating Expenses6.14M5.60M6.88M6.66M5.29MN/A
Operating Income-13.62M-15.85M-18.05M-17.28M-16.87M-7.65M
Other Expenses / Income5.45M-121.82K9.06M-4.73M-13.84M-24.84M
Before Tax Income-8.16M-20.04M-8.99M-22.01M-33.16M-32.49M
Income Tax ExpensesN/A7.00M368.66K-1.43M-645.87K-13.37K
Net Income-8.16M-27.04M-9.36M-20.59M-32.51M-32.47M
Interest Expenses536.14K596.02K368.66K3.05M13.84MN/A
Basic Shares Outstanding2.18M2.07M1.09M970.76K170.70K100.00K
Diluted Shares Outstanding2.18M2.07M1.09M970.76K170.70K100.00K
EBITDA-4.21M-13.73M-1.64M-12.21M-14.00M373.58K
EBITDA Margin-72.34%-229.06%-20.94%-127.72%-89.84%2.66%
EBIT-7.63M-19.44M-8.62M-18.96M-19.31M-32.49M
EBIT Margin-131.00%-324.46%-110.33%-198.36%-123.98%-231.20%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙